Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Endpoints News is a leading source of news and analysis for the biotech and pharmaceutical industries. It provides in-depth coverage of the latest developments, trends, and insights affecting the sector, including drug approvals, clinical trials, regulatory updates, and market dynamics.
360K
12000 / day
450K
15000 / day
3.8 min
2.5 pages per visit
40%
-
Domain Rating
-
Domain Authority
-
Citation Level
2015
English, etc
Website Key Features
Daily Newsletter
Receive a daily digest of the most important news and analysis in the biotech and pharmaceutical industries.
In-depth Analysis
Expert analysis and commentary on the latest trends, regulatory changes, and market dynamics.
Exclusive Interviews
Interviews with industry leaders, scientists, and regulatory officials providing unique insights.
Clinical Trial Updates
Comprehensive coverage of clinical trial results and their implications for the industry.
Regulatory News
Up-to-date information on FDA approvals, regulatory guidelines, and compliance issues.
Market Trends
Analysis of market trends, mergers and acquisitions, and investment opportunities in the biotech and pharmaceutical sectors.
Event Coverage
Live coverage and summaries of key industry events, conferences, and seminars.
Research and Development
Insights into the latest research and development efforts, including breakthrough therapies and technologies.
Policy and Legislation
Analysis of policy changes, legislation, and their impact on the biotech and pharmaceutical industries.
Career Resources
Resources and advice for professionals looking to advance their careers in the biotech and pharmaceutical sectors.
Similar Sites and Competitors
Additional information
Audience
Endpoints News is aimed at professionals in the biotech and pharmaceutical industries, including executives, scientists, regulatory officials, and investors.
Subscription Model
Offers both free and premium subscription options, with premium subscribers gaining access to exclusive content, in-depth reports, and advanced features.
Editorial Team
Comprised of experienced journalists and industry experts with deep knowledge of the biotech and pharmaceutical sectors.
Global Reach
While primarily focused on the U.S. market, Endpoints News also covers significant international developments affecting the global biotech and pharmaceutical industries.
Awards and Recognition
Endpoints News has received numerous awards for its journalism and has been recognized as a leading source of industry news and analysis.
HTTP headers
Security headers report is a very important part of user data protection. Learn more about http headers for endpts.com